FARO ECONÓMICOSTOCK ANALYSIS

VRTX — analysis and forecast

$504.18+0.9% todayVertex Pharmaceuticals Incorporated
Verdict
Neutral
RSI (14)
39
MACD
▼ falling
Trend
Downtrend
Volatility
28%
52w range
64%

🗓️ Forecast by horizon

Directional bias · probability of rising · expected price and likely range (68%)

HorizonBiasProb. upExpected price68% range
1 dayNeutral49%$504.23 +0.0%$495.38 – $513.24
3 daysNeutral49%$504.34 +0.0%$489.10 – $520.04
1 weekNeutral50%$504.44 +0.1%$484.86 – $524.82
15 daysNeutral50%$504.71 +0.1%$477.23 – $533.78
1 monthNeutral51%$505.30 +0.2%$465.92 – $548.02
3 monthsBullish53%$507.57 +0.7%$441.02 – $584.16

Recent momentum: -1.3% over 20 days · +5.6% over 60 days. The further out the horizon, the wider and more uncertain the forecast.

📈 Probability cone

📜 Government contracts

We have no notable federal contract on file for VRTX. You can look it up yourself at USASpending.gov or in the Government Sources hub.

🧠 How it is calculated

The verdict combines trend (20/50/200 moving averages), momentum (RSI, MACD), mean reversion (Bollinger Bands), conviction (volume) and historical drift, weighted differently for each horizon. Uncertainty is modeled with a lognormal probability cone (geometric Brownian motion). This is statistical analysis, not a crystal ball.

🔦 Keep analyzing

Other stocks Faro watches

🔮 Oracle Pro 📈 Trading Room 📅 Calendar

⚠️ Educational tool. Not financial advice. Forecasts are statistical estimates based on historical volatility; the market can do the opposite. Data via Yahoo Finance. Always verify before trading. The decisions are yours.